Trials / Recruiting
RecruitingNCT06474039
The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPD
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to demonstrate the effects of triple therapy (ICS/LABA/LAMA) and dual bronchodilators (LAMA/LABA) on air trapping in the lungs' COPD patients and inflammatory mediators
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trelegy or Anoro | Both drugs delivered via Ellipta device and blinded package appearance |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2026-06-01
- Completion
- 2026-12-01
- First posted
- 2024-06-25
- Last updated
- 2025-05-06
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT06474039. Inclusion in this directory is not an endorsement.